contract_awardAwarded Friday, August 28, 2026Analyzed

PFIZER INC: $45.5M Department of Health and Human Services Contract Vehicle

Neutral

Summary

Pfizer Inc received a $45.5M contract from the CDC for pediatric COVID vaccines for FY26-27. The award is routine and represents less than 0.04% of Pfizer's annual revenue, making it negligible for the company's financials.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.The $45.5M contract is a routine renewal with negligible financial impact on Pfizer.
  • 2.No legislative tailwind or sector-wide catalyst is present.
  • 3.Investors should not expect any material stock movement from this award.

Market Implications

The contract is too small to influence Pfizer's stock price. For retail investors, this is a non-event. The broader COVID vaccine market remains driven by commercial demand and new variant updates, not government procurement of this scale. No other publicly traded companies are meaningfully impacted.

Full Analysis

  1. The contract: Pfizer Inc was awarded a $45.5M indefinite delivery/indefinite quantity contract by the Centers for Disease Control and Prevention (CDC) to supply pediatric COVID-19 vaccines for the period June 2026 through May 2027, under Executive Order 14398. This is a continuation of the U.S. government's pediatric vaccination program. 2) The public company beneficiary: Pfizer Inc is the direct recipient. With annual revenue of $59.6B (FY2025), the $45.5M award over two years equates to roughly $22.75M per year, or 0.038% of revenue. This is far below the threshold of materiality. Pfizer's COVID vaccine revenue has fallen sharply from $36.8B in 2022 to an estimated $8-10B in 2025, so this contract provides a small, stable base but does not alter the company's trajectory. 3) Connection to legislation: No related bills in the provided database directly authorize or appropriate funds for pediatric COVID vaccines. The contract appears to be funded through existing HHS appropriations. 4) Supply chain winners: Pfizer manufactures the vaccine internally, but subcontractors for fill/finish, packaging, and distribution could include companies like Catalent ($CTLT) or Thermo Fisher Scientific ($TMO) for contract manufacturing, though specific subcontractors are not disclosed. These downstream beneficiaries would see minimal incremental revenue from this award. 5) Historical pattern: Government vaccine contracts for established products typically provide steady but low-margin revenue. Pfizer's stock has historically been more sensitive to COVID variant waves and commercial demand than to government procurement contracts of this size.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Contract Details

Recipient

PFIZER INC

Award Amount

$45,530,506

Awarding Agency

Department of Health and Human Services

Sub-Agency

Centers for Disease Control and Prevention

Contract Type

INDEFINITE DELIVERY / INDEFINITE QUANTITY

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →